Understanding the FDA's 2026 General Wellness Policy for Low-Risk Devices
- 13 hours ago
- 3 min read
The FDA updated its General Wellness policy in January 2026 to clarify how it regulates low-risk devices that promote a healthy lifestyle. This update is important for manufacturers and consumers alike because it defines which products fall outside the FDA’s device regulations. Understanding this policy helps companies avoid unnecessary regulatory hurdles and ensures consumers can confidently use wellness products designed to support their health without medical claims.
What the FDA’s General Wellness Policy Covers
The FDA’s Center for Devices and Radiological Health (CDRH) oversees medical devices, but not all health-related products are considered medical devices. The updated policy focuses on low-risk products that encourage healthy behaviors but do not claim to diagnose, treat, or prevent diseases.
Key points of the policy include:
Scope: Applies to products that promote a healthy lifestyle, such as fitness apps, wellness trackers, and meditation software.
Definition of a Device: Software or products intended only to maintain or encourage a healthy lifestyle are not considered medical devices under section 201(h) of the Federal Food, Drug, and Cosmetic Act.
Risk Level: The policy applies only to low-risk products that do not pose safety concerns.
This means many consumer wellness products can avoid the lengthy and costly FDA device approval process if they meet these criteria.
Why This Policy Update Matters
The wellness market has grown rapidly, with many new products claiming to improve health without medical intervention. Before this update, some companies faced uncertainty about whether their products needed FDA clearance. The 2026 policy provides clearer guidance, which benefits:
Manufacturers by reducing regulatory burdens for low-risk products.
Consumers by ensuring products are safe and appropriately regulated.
Healthcare providers by distinguishing wellness tools from medical devices.
For example, a company making a smartphone app that tracks daily steps and encourages exercise can now be confident it is not regulated as a medical device, as long as it does not claim to diagnose or treat conditions.
How to Determine if Your Product Qualifies as Low-Risk
Manufacturers should evaluate their products against the FDA’s criteria to confirm if they qualify for the low-risk category. Consider these factors:
Intended Use: Does the product only promote general wellness or a healthy lifestyle? Avoid claims about diagnosing or treating diseases.
Risk to Users: Is the product unlikely to cause harm if it malfunctions or is used incorrectly?
Technology Type: Is the product software or hardware designed for general wellness, such as fitness tracking or stress reduction?
If the answer to these questions aligns with the policy, the product likely falls outside the FDA’s device regulations.
Examples of Products Covered by the Policy
Here are some examples of products that typically qualify as low-risk under the updated policy:
Fitness trackers that monitor steps, heart rate, or sleep patterns without diagnosing conditions.
Mobile apps that provide reminders to drink water or encourage meditation.
Wearable devices that track physical activity but do not claim to detect or treat medical issues.
Software that offers nutritional tips or general health education.
These products support healthy habits without making medical claims, so they avoid the regulatory requirements for medical devices.
What Manufacturers Should Do Next
To comply with the updated policy, manufacturers should:
Review product claims carefully to ensure they do not imply medical use.
Document the intended use and risk assessment to demonstrate low-risk status.
Stay informed about FDA guidance and updates to maintain compliance.
Consult regulatory experts if unsure about classification.
Taking these steps helps avoid costly delays and ensures products reach the market smoothly.
Impact on Consumers and the Market
Consumers benefit from clearer distinctions between wellness products and medical devices. This clarity helps users understand what a product can and cannot do, reducing confusion and potential misuse.
The market also gains from innovation in wellness technology. Companies can focus on creating helpful tools without the burden of medical device regulations, encouraging more products that promote healthy lifestyles.
Summary
The FDA’s January 2026 update to its General Wellness policy provides clearer guidance on how the agency approaches low-risk products that support a healthy lifestyle. For manufacturers, the key is staying within general wellness intended use and avoiding claims that suggest diagnosing, treating, curing, mitigating, or preventing disease. When a product’s claims and risk profile align with the policy, companies can move forward with greater confidence, while still maintaining strong documentation and quality practices.
The updated General Wellness policy is a helpful roadmap for innovators, but it also draws a firm line between wellness support and medical device claims. If you develop or market a wellness product, take time to review your labeling, advertising, and app or device functionality to confirm your intended use remains in scope and your risk assessment supports a low-risk profile. A proactive review now can prevent regulatory surprises later and keep your product on track for a smooth path to market.
